Open Access Mini Review

Features of the Immune Response and Multisystem Inflammatory Syndrome in Children with COVID-19: A Mini-Review

Veronika Galichina1, Darya Sitovskaya1,2*, Alexander Chepelev1, Ruslan Nasyrov1

1Department of Pathology with a course of forensic medicine named after D.D. Lochov, St. Petersburg State Pediatric Medical University, Saint-Petersburg,Russia

2Polenov Neurosurgical Institute – Branch of Almazov National Medical Research Centre, St. Petersburg, Russia Veronika Galichina: https://orcid.org/0000-0001-8424-814X Darya Sitovskaya: https://orcid.org/0000-0001-9721-3827 Alexander Chepelev: https://orcid.org/0000-0002-4127-3457 Ruslan Nasyrov: https://orcid.org/0000-0001-8120-2816

Corresponding Author

Received Date:July 08, 2024;  Published Date:August 15, 2024

Abstract

On March 11, 2020, the World Health Organization declared a pandemic of severe acute respiratory syndrome (SARS) caused by coronavirus type 2 (SARS-CoV-2). Despite extensive treatment and preventive measures, COVID-19 remains one of the leading causes of severe morbidity and mortality among viral diseases. However, the disease is typically mild or asymptomatic in young people and children. In this mini-review, we will discuss the immune response and multisystem inflammatory syndrome in children with COVID-19.

Keywords:Children; COVID-19; Immune response; Multisystem inflammatory syndrome; MIS-C

Citation
Signup for Newsletter
Scroll to Top